Comparison of tissue characterization curves for different CT scanners: Implication in proton therapy treatment planning

Chee Wai Cheng, Li Zhao, Mark Wolanski, Qingya Zhao, Josuha James, Kate Dikeman, Michael Mills, Mei Li, Shiv P. Srivastava, Xing Qi Lu, Indra J. Das

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

For proton beam therapy, CT imaging is required to calculate dose based on CT pixel values of relative stopping power (RSP). The variation among CT-scanners and the phantom used to derive the relationship CT number-electron density-RSP has not been investigated. Using RMI CT phantoms, 18 CT scanners and a Tomotherapy unit, the Hounsfield unit (HU) variations and associated dosimetric uncertainty were investigated. The variation of HU was within one standard deviation (SD) of the average for 14 out of the 15 scanners tested with the same phantoms. For high density materials (> 400 HU) the HU values deviated by more than 4% from the average. The HU- RSP curves of 18 scanners were fitted with a straight line in three HU intervals: -700 <HU <0, 0 <HU <230 and <230 <HU <1,700. The dosimetric impacts of the variation of HU among scanners were <1% in DVH point dose comparisons in a prostate cancer plan. For a head and neck cancer plan the difference was up to 4% due to large inhomogeneities. Our results seem to suggest that the X-ray spectrum of a CT scanner has a smaller effect on the HU-RSP curve than the elemental compositions of the tissue substitutes used in the calibration. Furthermore, a single HU-RSP curve may suffice as a reference curve for proton treatment planning. It is found to agree with the calibration curve obtained for the specific scanner. This study does not address the issue of metallic implants included in the treatment plan.

Original languageEnglish (US)
Pages (from-to)236-246
Number of pages11
JournalTranslational Cancer Research
Volume1
Issue number4
DOIs
StatePublished - Dec 1 2012

Fingerprint

Proton Therapy
Calibration
Specific Gravity
Head and Neck Neoplasms
Uncertainty
Protons
Prostatic Neoplasms
X-Rays
Electrons
Therapeutics

Keywords

  • CT scanner
  • Dosimetric uncertainty
  • Electron density
  • Proton beam
  • Relative stopping power

ASJC Scopus subject areas

  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Cancer Research

Cite this

Comparison of tissue characterization curves for different CT scanners : Implication in proton therapy treatment planning. / Cheng, Chee Wai; Zhao, Li; Wolanski, Mark; Zhao, Qingya; James, Josuha; Dikeman, Kate; Mills, Michael; Li, Mei; Srivastava, Shiv P.; Lu, Xing Qi; Das, Indra J.

In: Translational Cancer Research, Vol. 1, No. 4, 01.12.2012, p. 236-246.

Research output: Contribution to journalArticle

Cheng, CW, Zhao, L, Wolanski, M, Zhao, Q, James, J, Dikeman, K, Mills, M, Li, M, Srivastava, SP, Lu, XQ & Das, IJ 2012, 'Comparison of tissue characterization curves for different CT scanners: Implication in proton therapy treatment planning', Translational Cancer Research, vol. 1, no. 4, pp. 236-246. https://doi.org/10.3978/j.issn.2218-676X.2012.11.05
Cheng, Chee Wai ; Zhao, Li ; Wolanski, Mark ; Zhao, Qingya ; James, Josuha ; Dikeman, Kate ; Mills, Michael ; Li, Mei ; Srivastava, Shiv P. ; Lu, Xing Qi ; Das, Indra J. / Comparison of tissue characterization curves for different CT scanners : Implication in proton therapy treatment planning. In: Translational Cancer Research. 2012 ; Vol. 1, No. 4. pp. 236-246.
@article{58ee1d481df04b60919a58edda5c2163,
title = "Comparison of tissue characterization curves for different CT scanners: Implication in proton therapy treatment planning",
abstract = "For proton beam therapy, CT imaging is required to calculate dose based on CT pixel values of relative stopping power (RSP). The variation among CT-scanners and the phantom used to derive the relationship CT number-electron density-RSP has not been investigated. Using RMI CT phantoms, 18 CT scanners and a Tomotherapy unit, the Hounsfield unit (HU) variations and associated dosimetric uncertainty were investigated. The variation of HU was within one standard deviation (SD) of the average for 14 out of the 15 scanners tested with the same phantoms. For high density materials (> 400 HU) the HU values deviated by more than 4{\%} from the average. The HU- RSP curves of 18 scanners were fitted with a straight line in three HU intervals: -700 <HU <0, 0 <HU <230 and <230 <HU <1,700. The dosimetric impacts of the variation of HU among scanners were <1{\%} in DVH point dose comparisons in a prostate cancer plan. For a head and neck cancer plan the difference was up to 4{\%} due to large inhomogeneities. Our results seem to suggest that the X-ray spectrum of a CT scanner has a smaller effect on the HU-RSP curve than the elemental compositions of the tissue substitutes used in the calibration. Furthermore, a single HU-RSP curve may suffice as a reference curve for proton treatment planning. It is found to agree with the calibration curve obtained for the specific scanner. This study does not address the issue of metallic implants included in the treatment plan.",
keywords = "CT scanner, Dosimetric uncertainty, Electron density, Proton beam, Relative stopping power",
author = "Cheng, {Chee Wai} and Li Zhao and Mark Wolanski and Qingya Zhao and Josuha James and Kate Dikeman and Michael Mills and Mei Li and Srivastava, {Shiv P.} and Lu, {Xing Qi} and Das, {Indra J.}",
year = "2012",
month = "12",
day = "1",
doi = "10.3978/j.issn.2218-676X.2012.11.05",
language = "English (US)",
volume = "1",
pages = "236--246",
journal = "Translational Cancer Research",
issn = "2218-676X",
publisher = "AME Publishing Company",
number = "4",

}

TY - JOUR

T1 - Comparison of tissue characterization curves for different CT scanners

T2 - Implication in proton therapy treatment planning

AU - Cheng, Chee Wai

AU - Zhao, Li

AU - Wolanski, Mark

AU - Zhao, Qingya

AU - James, Josuha

AU - Dikeman, Kate

AU - Mills, Michael

AU - Li, Mei

AU - Srivastava, Shiv P.

AU - Lu, Xing Qi

AU - Das, Indra J.

PY - 2012/12/1

Y1 - 2012/12/1

N2 - For proton beam therapy, CT imaging is required to calculate dose based on CT pixel values of relative stopping power (RSP). The variation among CT-scanners and the phantom used to derive the relationship CT number-electron density-RSP has not been investigated. Using RMI CT phantoms, 18 CT scanners and a Tomotherapy unit, the Hounsfield unit (HU) variations and associated dosimetric uncertainty were investigated. The variation of HU was within one standard deviation (SD) of the average for 14 out of the 15 scanners tested with the same phantoms. For high density materials (> 400 HU) the HU values deviated by more than 4% from the average. The HU- RSP curves of 18 scanners were fitted with a straight line in three HU intervals: -700 <HU <0, 0 <HU <230 and <230 <HU <1,700. The dosimetric impacts of the variation of HU among scanners were <1% in DVH point dose comparisons in a prostate cancer plan. For a head and neck cancer plan the difference was up to 4% due to large inhomogeneities. Our results seem to suggest that the X-ray spectrum of a CT scanner has a smaller effect on the HU-RSP curve than the elemental compositions of the tissue substitutes used in the calibration. Furthermore, a single HU-RSP curve may suffice as a reference curve for proton treatment planning. It is found to agree with the calibration curve obtained for the specific scanner. This study does not address the issue of metallic implants included in the treatment plan.

AB - For proton beam therapy, CT imaging is required to calculate dose based on CT pixel values of relative stopping power (RSP). The variation among CT-scanners and the phantom used to derive the relationship CT number-electron density-RSP has not been investigated. Using RMI CT phantoms, 18 CT scanners and a Tomotherapy unit, the Hounsfield unit (HU) variations and associated dosimetric uncertainty were investigated. The variation of HU was within one standard deviation (SD) of the average for 14 out of the 15 scanners tested with the same phantoms. For high density materials (> 400 HU) the HU values deviated by more than 4% from the average. The HU- RSP curves of 18 scanners were fitted with a straight line in three HU intervals: -700 <HU <0, 0 <HU <230 and <230 <HU <1,700. The dosimetric impacts of the variation of HU among scanners were <1% in DVH point dose comparisons in a prostate cancer plan. For a head and neck cancer plan the difference was up to 4% due to large inhomogeneities. Our results seem to suggest that the X-ray spectrum of a CT scanner has a smaller effect on the HU-RSP curve than the elemental compositions of the tissue substitutes used in the calibration. Furthermore, a single HU-RSP curve may suffice as a reference curve for proton treatment planning. It is found to agree with the calibration curve obtained for the specific scanner. This study does not address the issue of metallic implants included in the treatment plan.

KW - CT scanner

KW - Dosimetric uncertainty

KW - Electron density

KW - Proton beam

KW - Relative stopping power

UR - http://www.scopus.com/inward/record.url?scp=84962629585&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84962629585&partnerID=8YFLogxK

U2 - 10.3978/j.issn.2218-676X.2012.11.05

DO - 10.3978/j.issn.2218-676X.2012.11.05

M3 - Article

AN - SCOPUS:84962629585

VL - 1

SP - 236

EP - 246

JO - Translational Cancer Research

JF - Translational Cancer Research

SN - 2218-676X

IS - 4

ER -